Caricamento...

Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis

Previous studies have shown that administration of fibroblast growth factor-19 (FGF-19) reverses diabetes, hepatic steatosis, hyperlipidemia, and adipose accretion in animal models of obesity. To investigate the mechanism for this effect, we determined whether FGF-19 modulated hepatic fatty acid syn...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bhatnagar, Sushant, Damron, Holly A., Hillgartner, F. Bradley
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Biochemistry and Molecular Biology 2009
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2665057/
https://ncbi.nlm.nih.gov/pubmed/19233843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M808818200
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !